Menu
Back to User profile » Professor Leif Bjermer
Papers published by Professor Leif Bjermer:
Bronchodilator Responsiveness Measured by Spirometry and Impulse Oscillometry in Patients with Asthma After Short Acting Antimuscarinic and/or Beta-2-Agonists Inhalation
van der Burg NMD, Ekelund C, Bjermer LH, Aronsson D, Ankerst J, Tufvesson E
Journal of Asthma and Allergy 2024, 17:21-32
Published Date: 19 January 2024
Lung Fibroblasts from Chronic Obstructive Pulmonary Disease Subjects Have a Deficient Gene Expression Response to Cigarette Smoke Extract Compared to Healthy
Garcia-Ryde M, van der Burg NMD, Larsson CE, Larsson-Callerfelt AK, Westergren-Thorsson G, Bjermer L, Tufvesson E
International Journal of Chronic Obstructive Pulmonary Disease 2023, 18:2999-3014
Published Date: 18 December 2023
Adult Severe Asthma Registries: A Global and Growing Inventory
Cushen B, Koh MS, Tran TN, Martin N, Murray R, Uthaman T, Goh CYY, Vella R, Eleangovan N, Bulathsinhala L, Maspero JF, Peters MJ, Schleich F, Pitrez P, Christoff G, Sadatsafavi M, Torres-Duque CA, Porsbjerg C, Altraja A, Lehtimäki L, Bourdin A, Taube C, Papadopoulos NG, Zsuzsanna C, Björnsdóttir U, Salvi S, Heffler E, Iwanaga T, al-Ahmad M, Larenas-Linnemann D, van Boven JF, Aarli BB, Kuna P, Loureiro CC, Al-lehebi R, Lee JH, Marina N, Bjermer L, Sheu CC, Mahboub B, Busby J, Menzies-Gow A, Wang E, Price DB
Pragmatic and Observational Research 2023, 14:127-147
Published Date: 20 October 2023
Characterization of Patients in the International Severe Asthma Registry with High Steroid Exposure Who Did or Did Not Initiate Biologic Therapy
Chen W, Sadatsafavi M, Tran TN, Murray RB, Wong CBN, Ali N, Ariti C, Garcia Gil E, Newell A, Alacqua M, Al-Ahmad M, Altraja A, Al-Lehebi R, Bhutani M, Bjermer L, Bjerrum AS, Bourdin A, Bulathsinhala L, von Bülow A, Busby J, Canonica GW, Carter V, Christoff GC, Cosio BG, Costello RW, FitzGerald JM, Fonseca JA, Yoo KH, Heaney LG, Heffler E, Hew M, Hilberg O, Hoyte F, Iwanaga T, Jackson DJ, Jones RC, Koh MS, Kuna P, Larenas-Linnemann D, Lehmann S, Lehtimäki LA, Lyu J, Mahboub B, Maspero J, Menzies-Gow AN, Sirena C, Papadopoulos N, Papaioannou AI, Pérez de Llano L, Perng DW, Peters M, Pfeffer PE, Porsbjerg CM, Popov TA, Rhee CK, Salvi S, Taillé C, Taube C, Torres-Duque CA, Ulrik CS, Ra SW, Wang E, Wechsler ME, Price DB
Journal of Asthma and Allergy 2022, 15:1491-1510
Published Date: 21 October 2022
Economic Evaluation of Umeclidinium/Vilanterol versus Umeclidinium or Salmeterol in Symptomatic Non-Exacerbating Patients with COPD from a UK Perspective Using the GALAXY Model
Shukla S, Shah D, Martin A, Risebrough NA, Kendall R, Vogelmeier CF, Boucot I, Tombs L, Bjermer L, Jones PW, Kerwin E, Compton C, Maltais F, Lipson DA, Ismaila AS
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:3105-3118
Published Date: 13 November 2021
Dual Bronchodilator Therapy as First-Line Treatment in Maintenance-Naïve Patients with Symptomatic COPD: A Pre-Specified Analysis of the EMAX Trial
Bjermer L, Boucot IH, Maltais F, Kerwin EM, Naya IP, Tombs L, Jones PW, Compton C, Lipson DA, Vogelmeier CF
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1939-1956
Published Date: 28 June 2021
Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD [Corrigendum]
Tufvesson E, Radner F, Papapostolou G, Jarenbäck L, Jönsson S, Nihlén U, Ankerst J, Tunsäter A, Peterson S, Bjermer L, Eriksson G
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1413-1414
Published Date: 20 May 2021
Treatment of COPD with Long-Acting Bronchodilators: Association Between Early and Longer-Term Clinically Important Improvement
Vogelmeier CF, Naya IP, Maltais F, Bjermer L, Kerwin EM, Tombs L, Jones PW, Compton C, Lipson DA, Boucot IH
International Journal of Chronic Obstructive Pulmonary Disease 2021, 16:1215-1226
Published Date: 3 May 2021
Reduced Variability of Endurance Time in New Protocols for Exercise Tests in COPD
Tufvesson E, Radner F, Papapostolou G, Jarenbäck L, Jönsson S, Nihlén U, Ankerst J, Tunsäter A, Peterson S, Bjermer L, Eriksson G
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:3003-3012
Published Date: 19 November 2020
Type 2 Inflammatory Biomarker Response After Exercise Challenge Testing
Tufvesson E, Stenberg H, Ankerst J, Bjermer L
Journal of Asthma and Allergy 2020, 13:269-274
Published Date: 24 August 2020
A multicenter, open-label, noninterventional study to evaluate the impact on clinical effects, user-friendliness and patients’ acceptance of AirFluSal Forspiro in the treatment of asthma under real-life conditions (ASSURE)
Backer V, Bjermer L, Refvem OK, Søderman A, Jones S
Pragmatic and Observational Research 2019, 10:29-39
Published Date: 24 May 2019
Effects of baseline symptom burden on treatment response in COPD
Martinez FJ, Abrahams RA, Ferguson GT, Bjermer L, Grönke L, Voß F, Singh D
International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:181-194
Published Date: 4 January 2019
The Efficiency Index (EFFi), based on volumetric capnography, may allow for simple diagnosis and grading of COPD
Jarenbäck L, Tufvesson E, Ankerst J, Bjermer L, Jonson B
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2033-2039
Published Date: 27 June 2018
Inflammation and chronic colonization of Haemophilus influenzae in sputum in COPD patients related to the degree of emphysema and bronchiectasis in high-resolution computed tomography
Tufvesson E, Markstad H, Bozovic G, Ekberg M, Bjermer L
International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3211-3219
Published Date: 1 November 2017
Asthma symptoms, mannitol reactivity and exercise-induced bronchoconstriction in adolescent swimmers versus tennis players
Romberg K, Tufvesson E, Bjermer L
Journal of Asthma and Allergy 2017, 10:249-260
Published Date: 3 October 2017
Asthma referrals: a key component of asthma management that needs to be addressed
Price D, Bjermer L, Bergin DA, Martinez R
Journal of Asthma and Allergy 2017, 10:209-223
Published Date: 25 July 2017
Bronchodilator response of advanced lung function parameters depending on COPD severity
Jarenbäck L, Eriksson G, Peterson S, Ankerst J, Bjermer L, Tufvesson E
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:2939-2950
Published Date: 25 November 2016
Two Phase II randomized trials on the CRTh2 antagonist AZD1981 in adults with asthma
Kuna P, Bjermer L, Tornling G
Drug Design, Development and Therapy 2016, 10:2759-2770
Published Date: 31 August 2016
The lung function profile of once-daily tiotropium and olodaterol via Respimat® is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler® (ENERGITO® study)
Beeh KM, Derom E, Echave-Sustaeta J, Grönke L, Hamilton A, Zhai D, Bjermer L
International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:193-205
Published Date: 3 February 2016
A new approach to assess COPD by identifying lung function break-points
Eriksson G, Jarenbäck L, Peterson S, Ankerst J, Bjermer L, Tufvesson E
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2193-2202
Published Date: 14 October 2015
Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilus influenzae during stable disease phase have increased airway inflammation
Tufvesson E, Bjermer L, Ekberg M
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:881-889
Published Date: 4 May 2015
Clinical pharmacokinetics of AZD3199, an inhaled ultra-long-acting β2-adrenoreceptor agonist (uLABA)
Bjermer L, Kuna P, Jorup C, Bengtsson T, Rosenborg J
Drug Design, Development and Therapy 2015, 9:753-762
Published Date: 5 February 2015
The added value of hybrid ventilation/perfusion SPECT/CT in patients with stable COPD or apparently healthy smokers. Cancer-suspected CT findings in the lungs are common when hybrid imaging is used
Jögi J, Markstad H, Tufvesson E, Bjermer L, Bajc M
International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:25-30
Published Date: 18 December 2014